MYDECINE INNOVATIONS GROUP INC.MYDECINE INNOVATIONS GROUP INC.MYDECINE INNOVATIONS GROUP INC.

MYDECINE INNOVATIONS GROUP INC.

No trades
See on Supercharts

MYCO fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Mydecine Innovations Group, Inc. is a biotechnology company. It engages in the business of creating the latest novel drugs and therapies to treat mental health conditions like nicotine addiction and post-traumatic stress disorder. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

MYCO does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company